BVS vs IT · rev $573.3M vs P/E 16, rev $6.27B
Bioventus Inc (BVS) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BVS currently screens at market cap $495.1M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BVS and IT stock pages for the full models.
Not investment advice.